secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001104659-25-098523
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood Pharmaceuticals director Andrew Dreyfus resigns effective Nov 1, 2025
------------------------------------------------------------------------------

- Andrew Dreyfus resigned from the Board, effective November 1, 2025.
- Resignation due to his appointment as President and CEO of NIHCM Foundation.
- No disagreement with Ironwood's operations, policies, or practices.
- Company expressed gratitude for his service on the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925098523/0001104659-25-098523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925098523/tm2528244d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer